Xingxing Zang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Acute Myeloid Leukemia

Cell Cycle Arrest

Top Venues

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, Negar Sadeghipour, Joanne Xiu, Kirsten Moziak, Rita M Yazejian, Rachel L Welch, W Robert Bell, Soma Sengupta, Sonikpreet Aulakh, Charles G Eberhart, David M Loeb, Emad Eskandar, Deyou Zheng, Xingxing Zang, Allison M Martin
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma. Cancers 16 (15) (2024)
Christopher D Nishimura, Devin T Corrigan, Xiang Yu Zheng, Phillip M Galbo, Shan Wang, Yao Liu, Yao Wei, Linna Suo, Wei Cui, Nadia Mercado, Deyou Zheng, Cheng Cheng Zhang, Xingxing Zang
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors. Science advances 10 (19) (2024)
Natalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, Negar Sadeghipour, Joanne Xiu, Kirsten Moziak, Rita M Yazejian, Rachel L Welch, W Robert Bell, Soma Sengupta, Sonikpreet Aulakh, Charles G Eberhart, David M Loeb, Emad Eskandar, Deyou Zheng, Xingxing Zang, Allison M Martin
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma. Cancers 16 (15) (2024)
Huijie Liu, Ayse Ece Cali Daylan, Jihua Yang, Ankit Tanwar, Alain Borczuk, Dongwei Zhang, Vincent Chau, Shenduo Li, Xuan Ge, Balazs Halmos, Xingxing Zang, Haiying Cheng
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints. Cancers 16 (16) (2024)
Hao Wang, R Alejandro Sica, Gurbakhash Kaur, Phillip M Galbo, Zhixin Jing, Christopher D Nishimura, Xiaoxin Ren, Ankit Tanwar, Bijan Etemad-Gilbertson, Britta Will, Deyou Zheng, David Fooksman, Xingxing Zang
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature communications 15 (1) (2024)
Christopher D Nishimura, Devin T Corrigan, Xiang Yu Zheng, Phillip M Galbo, Shan Wang, Yao Liu, Yao Wei, Linna Suo, Wei Cui, Nadia Mercado, Deyou Zheng, Cheng Cheng Zhang, Xingxing Zang
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors. Science advances 10 (19) (2024)
Natalia Muñoz Perez, Juliana M Pensabene, Phillip M Galbo, Negar Sadeghipour, Joanne Xiu, Kirsten Moziak, Rita M Yazejian, Rachel L Welch, W Robert Bell, Soma Sengupta, Sonikpreet Aulakh, Charles G Eberhart, David M Loeb, Emad Eskandar, Deyou Zheng, Xingxing Zang, Allison M Martin
VISTA Emerges as a Promising Target against Immune Evasion Mechanisms in Medulloblastoma. Cancers 16 (15) (2024)
Yanhong Li, Yifei Sang, Yunjian Chang, Chunfang Xu, Yikong Lin, Yao Zhang, Philip C N Chiu, William Shu Biu Yeung, Haisheng Zhou, Ningzheng Dong, Ling Xu, Jiajia Chen, Weijie Zhao, Lu Liu, Di Yu, Xingxing Zang, Jiangfeng Ye, Jinying Yang, Qingyu Wu, Da-Jin Li, Ligang Wu, Mei-Rong Du
A Galectin-9-Driven CD11c high Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia. Circulation 149 (21) (2024)
Hao Wang, R Alejandro Sica, Gurbakhash Kaur, Phillip M Galbo, Zhixin Jing, Christopher D Nishimura, Xiaoxin Ren, Ankit Tanwar, Bijan Etemad-Gilbertson, Britta Will, Deyou Zheng, David Fooksman, Xingxing Zang
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature communications 15 (1) (2024)
Christopher D Nishimura, Devin T Corrigan, Xiang Yu Zheng, Phillip M Galbo, Shan Wang, Yao Liu, Yao Wei, Linna Suo, Wei Cui, Nadia Mercado, Deyou Zheng, Cheng Cheng Zhang, Xingxing Zang
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors. Science advances 10 (19) (2024)
Yanhong Li, Yifei Sang, Yunjian Chang, Chunfang Xu, Yikong Lin, Yao Zhang, Philip C N Chiu, William Shu Biu Yeung, Haisheng Zhou, Ningzheng Dong, Ling Xu, Jiajia Chen, Weijie Zhao, Lu Liu, Di Yu, Xingxing Zang, Jiangfeng Ye, Jinying Yang, Qingyu Wu, Da-Jin Li, Ligang Wu, Mei-Rong Du
A Galectin-9-Driven CD11c high Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia. Circulation 149 (21) (2024)
Hao Wang, R Alejandro Sica, Gurbakhash Kaur, Phillip M Galbo, Zhixin Jing, Christopher D Nishimura, Xiaoxin Ren, Ankit Tanwar, Bijan Etemad-Gilbertson, Britta Will, Deyou Zheng, David Fooksman, Xingxing Zang
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature communications 15 (1) (2024)
Yanhong Li, Yifei Sang, Yunjian Chang, Chunfang Xu, Yikong Lin, Yao Zhang, Philip C N Chiu, William Shu Biu Yeung, Haisheng Zhou, Ningzheng Dong, Ling Xu, Jiajia Chen, Weijie Zhao, Lu Liu, Di Yu, Xingxing Zang, Jiangfeng Ye, Jinying Yang, Qingyu Wu, Da-Jin Li, Ligang Wu, Mei-Rong Du
A Galectin-9-Driven CD11c high Decidual Macrophage Subset Suppresses Uterine Vascular Remodeling in Preeclampsia. Circulation (2024)
Huijie Liu, Ayse Ece Cali Daylan, Jihua Yang, Ankit Tanwar, Alain Borczuk, Dongwei Zhang, Vincent Chau, Shenduo Li, Xuan Ge, Balazs Halmos, Xingxing Zang, Haiying Cheng
Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints. Cancers 16 (16) (2024)
Christopher D Nishimura, Devin T Corrigan, Xiang Yu Zheng, Phillip M Galbo, Shan Wang, Yao Liu, Yao Wei, Linna Suo, Wei Cui, Nadia Mercado, Deyou Zheng, Cheng Cheng Zhang, Xingxing Zang
TOP CAR with TMIGD2 as a safe and effective costimulatory domain in CAR cells treating human solid tumors. Science advances 10 (19) (2024)
Hao Wang, R Alejandro Sica, Gurbakhash Kaur, Phillip M Galbo, Zhixin Jing, Christopher D Nishimura, Xiaoxin Ren, Ankit Tanwar, Bijan Etemad-Gilbertson, Britta Will, Deyou Zheng, David Fooksman, Xingxing Zang
TMIGD2 is an orchestrator and therapeutic target on human acute myeloid leukemia stem cells. Nature communications 15 (1) (2024)
Marc C Pulanco, Anne Tranberg Madsen, Ankit Tanwar, Devin T Corrigan, Xingxing Zang
Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies. Cellular & molecular immunology (2023)
Phillip M Galbo, Anne Tranberg Madsen, Yang Liu, Mou Peng, Yao Wei, Michael J Ciesielski, Robert A Fenstermaker, Sarah Graff, Cristina Montagna, Jeffrey E Segall, Simone Sidoli, Xingxing Zang, Deyou Zheng
Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yao Wei, Xiaoxin Ren, Phillip M Galbo, Scott Moerdler, Hao Wang, R Alejandro Sica, Bijan Etemad-Gilbertson, Lei Shi, Liqiang Zhu, Xudong Tang, Qi Lin, Mou Peng, Fangxia Guan, Deyou Zheng, Jordan M Chinai, Xingxing Zang
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target. Science immunology 6 (61) (2022)
Peter John, Marc C Pulanco, Phillip M Galbo, Yao Wei, Kim C Ohaegbulam, Deyou Zheng, Xingxing Zang
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy. Nature communications 13 (1) (2022)
Elodie Picarda, Phillip M Galbo, Haihong Zong, Meenu Rohini Rajan, Ville Wallenius, Deyou Zheng, Rajat Singh, Jeffrey E Pessin, Xingxing Zang
The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development. Science advances 8 (17) (2022)
Phillip M Galbo, Xingxing Zang, Deyou Zheng
Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Yuxin Li, Yao Liu, Na Zhao, Xiaojun Yang, Yaqing Li, Fangzheng Zhai, Xingxing Zang, Wei Cui
Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer. Cell death & disease 11 (9) (2020)